Owen Catherine E.
Insider CIK 1816838 · ACAD Chief Executive Officer, Director · AGIO Director · OPTN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2026-06-18 | 2026-06-23 | 2,927 | — | $0 | 2,927 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2026-06-18 | 2026-06-23 | 14,950 | — | $0 | 14,950 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 10,865 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2026-06-13 | 2026-06-16 | 1,976 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2026-06-13 | 2026-06-16 | 1,976 | — | $0 | 8,049 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2026-03-25 | 2026-03-26 | 11,641 | $21.47 | $249.9K | 14,803 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2026-03-24 | 2026-03-26 | 23,509 | — | $0 | 70,530 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2026-03-24 | 2026-03-26 | 23,509 | — | $0 | 26,444 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2026-03-06 | 2026-03-10 | 263,005 | — | $0 | 263,005 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2026-03-06 | 2026-03-10 | 76,509 | — | $0 | 76,509 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 6,073 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2025-06-18 | 2025-06-23 | 15,768 | — | $0 | 15,768 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2025-06-18 | 2025-06-23 | 2,816 | — | $0 | 2,816 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2025-06-13 | 2025-06-17 | 1,977 | — | $0 | 1,976 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2025-06-13 | 2025-06-17 | 1,977 | — | $0 | 3,953 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2025-03-24 | 2025-03-26 | 94,039 | — | $0 | 94,039 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2025-03-24 | 2025-03-26 | 319,976 | — | $0 | 319,976 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2024-09-23 | 2024-09-25 | 353,261 | — | $0 | 353,261 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2024-06-20 | 2024-06-24 | 11,774 | — | $0 | 11,774 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2024-06-20 | 2024-06-24 | 2,120 | — | $0 | 2,120 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2024-06-13 | 2024-06-17 | 1,976 | — | $0 | 3,953 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2024-06-13 | 2024-06-17 | 1,976 | — | $0 | 1,976 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2024-06-06 | 2024-06-07 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2023-06-13 | 2023-06-15 | 5,929 | — | $0 | 5,929 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2023-06-13 | 2023-06-15 | 33,177 | — | $0 | 33,177 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2023-06-08 | 2023-06-09 | 53,500 | — | $0 | 53,500 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2022-06-08 | 2022-06-09 | 32,000 | — | $0 | 32,000 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2021-06-09 | 2021-06-10 | 14,439 | — | $0 | 14,439 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2020-07-29 | 2020-07-30 | 28,879 | — | $0 | 28,879 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2020-07-29 | 2020-07-30 | 28,879 | — | $0 | 28,879 | SEC↗ |